Tango Therapeutics, Inc. (TNGX) Net Income by Year
Tango Therapeutics, Inc. reported a net loss of $101.6M in fiscal year 2025. This represents an increase of 22.0% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $123.7M net loss. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Tango Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TNGX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
TNGX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Tango Therapeutics, Inc. financials
Frequently Asked Questions
What was Tango Therapeutics, Inc.'s net income in fiscal year 2025?
Tango Therapeutics, Inc. reported a net loss of $101.6M in fiscal year 2025.
How fast is Tango Therapeutics, Inc.'s net income growing?
Tango Therapeutics, Inc. (TNGX) net income rose by 22.0% year over year, from -$130.3M to -$101.6M in fiscal year 2025.
What is Tango Therapeutics, Inc.'s net income over the last twelve months?
Tango Therapeutics, Inc. (TNGX) reported a $123.7M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Tango Therapeutics, Inc.'s net income changed over the years?
Across the 6 fiscal years this page covers, Tango Therapeutics, Inc. (TNGX) net income went from -$52.0M in fiscal year 2020 to -$101.6M in fiscal year 2025.
What was Tango Therapeutics, Inc.'s net income in the most recent quarter?
Tango Therapeutics, Inc. (TNGX) reported -$55.3M in net income in Q2 2026. This represents a decrease of 42.4% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Tango Therapeutics, Inc. (TNGX) reported on that line in every period on record.